Vascularization in Tissue Engineering: Angiogenesis versus Inosculation
European Surgical Research · 2012 · 48 (2) · 85-92
DOI: 10.1159/000336876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Surgical Research, online erschienen am 28.03.2012. Verfasst von M W Laschke und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Experimental Surgery, University of Saarland, Homburg/Saar, Germany. matthias.laschke@uks.eu. Hauptthemen laut MEDLINE: Neovascularization, Physiologic, Tissue Engineering. Die Arbeit wurde bisher 184-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Background/Purpose: The key challenge in tissue engineering is the establishment of an efficient vascularization for tissue constructs guaranteeing long-term survival and function. Vascularization may be achieved by the stimulation of angiogenesis or the inosculation of preformed microvascular networks within the implants to the host microvasculature. The present review provides an overview of these two concepts applied in tissue engineering.
Methods
A literature search was performed in PubMed for publications focusing on vascularization, angiogenesis and inosculation in tissue engineering.
Results
Several strategies have been proposed to stimulate the ingrowth of new blood vessels into tissue constructs. These include the modification of the chemical composition and architecture of scaffolds, their bioactivation by incorporation of growth factor delivery systems or by cell seeding as well as the stimulation of stem cell recruitment. However, because angiogenesis is a time-consuming process, all of these approaches cannot prevent ischemic cell death within larger 3-dimensional tissue constructs during the initial phase after implantation. To overcome this problem, in vitro or in situ prevascularization has emerged as a novel concept in tissue engineering. This bears the advantage that preformed microvascular networks within tissue constructs simply have to inosculate with the host microvasculature at the implantation site to get completely blood-perfused within a short period of time.
Conclusions
During the last years, considerable progress has been made in the development of promising vascularization strategies in tissue engineering. Particularly the inosculation of preformed microvascular networks has the great potential to markedly improve the survival of tissue constructs after implantation. The optimization of this vascularization strategy may pave the way for a broad clinical use of tissue engineering applications in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Clinical and Experimental Surgery, University of Saarland, Homburg/Saar, Germany. matthias.laschke@uks.eu
Zitieren
APA
Laschke, M. W., & Menger, M. D. (2012). Vascularization in Tissue Engineering: Angiogenesis versus Inosculation. European Surgical Research, 48(2), 85-92. https://doi.org/10.1159/000336876
Vancouver
Laschke MW, Menger MD. Vascularization in Tissue Engineering: Angiogenesis versus Inosculation. European Surgical Research. 2012;48(2):85-92. doi:10.1159/000336876
BibTeX
@article{Laschke2012,
author = {Laschke, M W and Menger, M D},
title = {Vascularization in Tissue Engineering: Angiogenesis versus Inosculation},
journal = {European Surgical Research},
year = {2012},
volume = {48},
number = {2},
pages = {85--92},
doi = {10.1159/000336876}
}
EUVIMED